In a captivating conversation, Elise de Reus, co-founder of Cradle Bio, delves into how generative AI is revolutionizing protein engineering. She explains how this innovative tech accelerates the development of biotherapeutics and sustainable industrial processes. Elise discusses the challenges of optimizing protein properties and the iterative design process with AI. With $33 million raised in funding, she shares ambitious plans for advancing AI in protein design, promising to reshape the future of biotechnology.